Recently, Orion Market Research (OMR) published a market research report on the Global Cardiac Biomarker Market.The Global Cardiac Biomarkers Market is anticipated to grow at a CAGR of 7.1% by 2023. According to the World Health Organization, in 2015, around 17.7 million of people died due to cardiovascular diseases and out of these 7.4 million were affected due to coronary heart diseases and an approximately 6.7 million dues to heat stroke. Cardiac biomarkers are utilized to detect and measure the risk factor associated with heart diseases. The cardiac biomarkers have been successfully tested to provide a more accurate prediction of heart failure after chest pain compared to more conventional methods. This is a major factor which may fuel the growth of the market. The market is also affected by the technological development of cardiac biomarker.

Browse the full report of “Cardiac Biomarker Market, by Type (Creatine Kinase, Troponins, Myoglobin, Natriuretic Peptides, Ischemia Modified Albumin, Others), by Application (Myocardial Infraction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others), by Location of Testing (Laboratory Testing, Point of Care Testing) – Global Trends, Market Size, Share, Growth, Research and Forecast 2018-2023” at https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market/

Furthermore, the global cardiac biomarker market is segmented on the basis of type, application, and location of testing. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Cardiac Biomarker Market by Type
  • Creatine Kinase(ck-mb)
  • Troponins(t,i)
  • Myoglobin
  • Natriuretic Peptides (bnp & nt-probnp)
  • Ischemia Modified Albumin
  • Others

2. Cardiac Biomarker Market by Application
  • Myocardial Infraction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

3. Cardiac Biomarker Market by Location of Testing
  • Laboratory Testing
  • Point of Care Testing

Region Covered
  • North America (the US and Canada)
  • Europe (UK, Germany, France, Spain, and Italy)
  • Asia-Pacific (China, India, South Korea, and Japan)
  • Rest of the World (the Middle East & Africa and Latin America)

Visit here to know more about Cardiac Biomarker Market study   https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market/

Company Profile
  • Abbott Diagnostics
  • Alere, Inc.
  • Becton, Dickson & Co.
  • BG Medicine, Inc.
  • Biomerieux
  • Bio-Rad Laboratories, Inc.

To know more information, please request a free report sample  https://www.omrglobal.com/request-sample/cardiac-biomarkers-market

The key objectives of the Cardiac Biomarker Market study:
  • To analyze the Cardiac Biomarker Market size (values and volume) by Type, by Application, by Location of Testing with historical data of 2017 and 2018 and forecast to 2025.
  • To study the key factors influencing the growth of the Cardiac Biomarker Market.
  • Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
  • To analyze the Cardiac Biomarker Market growth, global trends, future prospectus and contribution to the market.


About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404

0 Comments